NEW YORK Feb. 20, 2020 /PRNewswire/ — JDRF, a global leader in type 1 diabetes (T1D) research, today announced the appointment of two long-time volunteers to lead its International Board of Directors (IBOD). The two take office when the terms of current board leaders expire July 1, 2020. JDRF’s IBOD named Joseph P.
